deCODE genetics Announces Full-year 2004 Financial Results
08-Mar-2005 -
deCODE genetics announced its consolidated financial results for the year ended December 31, 2004. Revenue for the year ended December 31, 2004 was $42.1 million, versus $46.8 million for the year ended December 31, 2003. This reflects the gradual redeployment of the discovery and product ...
atherosclerosis
drug development
myocardial infarction
+1